Thank you @CIHR_IRSC @SCC_CCS for this award which I don’t deserve so early in mid-career, but which I’m grateful for. Indebted to my family, team, collaborators, funders, & to 🇨🇦 for giving this immigrant a chance. So grateful to my nominators. Miss you, dad. this one’s for you.

RT @TorBiering: Thanks @hvanspall! It was such an honor for us all that you and so many of our friends and collaborators decided to join th….

Join millions who have switched to Grok.

Said no to everything.Other than two sweet teens.And these countless shades .Of #blue and #green. #HomeSweetHome 🇨🇦

RT @DrJMieres: Celebrating @drstaceyrosen on becoming @American_Heart President (2025–26)! A trailblazer for women’s heart health. https:/….

I was so happy to celebrate @TorBiering’s outstanding presentations & sim pubs at #ESCcongress! . Amazing to carve out a career path that is uniquely one’s own, while pouring in so much effort into mentees. Proud of you, friend. 👏 . @CTCPR_

RT @brendonneuen: Do we have it the wrong way around?. Reduced GFR is cited as a reason to defer simultaneous initiation of #kidneyGDMT due….

Among 6105 patients w #HFrEF (no recent worsening, NTpBNP 600-6000), #vericiguat vs placebo ↔️ risk of composite #CV death or #heartfailure hospitalization. However, ⬇️ CV deaths noted in vericiguat group! . Unexpected?. Hear Prof @FaiezZANNAD discuss #VICTOR #RCT. #ESCCongress

Excited to welcome @FudimMarat @DCRINews to present at McMaster Regional Cardiology GrandRounds. What’s new in device based therapies to manage #heartfailure. Tuesday Sept 9, 2025.8 am EST. Via Teams .@PHRIresearch

Delighted to welcome #JustinHipolito & #CarloBorghese, new grad students on our team. Justin -deep in grant applications & trial ops already- will focus on #methodology research. Carlo brings cardiometabolic expertise from @Boehringer & will focus on #CKM research. Let’s go team!

RT @AndrewJSauer: #HFSA will be 🔥 🔥 🔥 this month. I’ll be on stage or at table for:. 1. Devices in HF (Fri and Sat).2. AIM HIGHER for Tri….

RT @m4ggiesimpson: 📣 Calling all cardiovascular nurses & allied professionals!.📝 Take our short #ACNAP survey to share your views on the Co….

In a 2-country open label pragmatic RCT of 5,574 ppl w #MI, LVEF ≥40%, & no HF, #BBs ⬇️primary composite outcome of ☠️ or MACE by 15%, w hint of larger benefit at lower EF #BetaMIDanblock. We discuss implications along with divergent #REBOOT trial results. Thoughts? #ESCCongress

Slides from #ESCcongress talk on #Cardiometabolic #drugs in the landscape of #HFmrEF & #HFpEF treatment. What an exciting era we are in, with more trials to come in this space. Is your therapeutic approach aligned with the current evidence? . #HeartFailure #CKM

RT @mmamas1973: Our work led by @MustafaAjlan published yesterday following #ESCCongress presentation . Abdominal aortic calcification a po….

RT @biljana_parapid: “No act of kindness, no matter how small, is ever wasted.”. Aesop / Αίσωπος.c. 620–564 BCE. Ran into it earlier today….

#DigitHF demonstrated an 18% reduction in death & HHF with digitoxin vs placebo on top of GDMT in only 1212 patients w advanced HFrEF (36 mo)!. Efficacy driven by 📉 in ☠️ + 🏥 . What is #digitoxin & how does the evidence fit into current Tx? Listen @radcliffeCARDIO.#ESCCongress

RT @Atul_Gawande: 9 CDC Directors going back to 1977 speak out. What RFK Jr has done to our nation’s public health system "should alarm eve….

Love my @CircAHA editorial team & boss! . #Circulation #Madrid #ESCCongress

RT @radcliffeCARDIO: 🎙️NEW #ESCCongress 2025 🔥 Hot Line Discussion 🌟 Prof Udo Bavendiek joins host Dr @hvanspall to explore findings from t….

RT @slumberbell: @DrMarthaGulati @escardio @worldheartfed @purviparwani @iamritu @Hragy 👏👏👏 Powerful speech by the Spanish Minister of Heal….

RT @krychtiukmd: How to overcome barriers to Developing and Implementing Novel Therapies for Hypertension?. The proceedings of a multistake….